Page last updated: 2024-10-18

dalteparin and chronic COVID syndrome

dalteparin has been researched along with chronic COVID syndrome in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"Coronavirus is a source of deep venous thrombosis (DVT) due to complications such as over-coagulation, blood stasis, and endothelial damage."1.62Ovarian vein thrombosis after coronavirus disease (COVID-19) mimicking acute abdomen: two case reports. ( Abdeladim, S; Bensahi, I; Elouarradi, A; Fatimazahra, M; Harras, ME; Kassimi, M; Oualim, S; Sabry, M, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fatimazahra, M1
Harras, ME1
Bensahi, I1
Kassimi, M1
Oualim, S1
Elouarradi, A1
Abdeladim, S1
Sabry, M1

Other Studies

1 other study available for dalteparin and chronic COVID syndrome

ArticleYear
Ovarian vein thrombosis after coronavirus disease (COVID-19) mimicking acute abdomen: two case reports.
    Journal of thrombosis and thrombolysis, 2021, Volume: 52, Issue:2

    Topics: Abdomen, Acute; Adult; Anticoagulants; COVID-19; Diagnosis, Differential; Enoxaparin; Female; Fibrin

2021